Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034

Description

Over-the-counter (OTC) drugs are medications available for purchase without a prescription from a healthcare professional. They are designed for self-care, allowing individuals to manage common health issues such as headaches, colds, allergies and digestive problems.

The over the counter (OTC) drugs market consists of sales by entities (organizations, sole traders and partnerships) of over the counter (OTC) drugs that are typically used when symptoms are mild to moderate and do not require a doctor's intervention. OTC drugs often serve as the first line of treatment for minor ailments and can act as substitutes for prescription medications in certain situations. They are widely used across various settings, including homes, workplaces and while traveling, providing convenient relief from everyday health concerns.

The global over the counter (OTC) drugs market was valued at $125,906.54 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 4.00%.

Increasing Investment in Research And Development

The increasing investment in research and development contributed to the growth of the over-the-counter (OTC) drugs market in the historic period. The increasing investment in research and development (R&D) drives the growth of the over-the-counter (OTC) drug by driving innovation in self-care treatments. This investment has led to the development of more effective, safer and targeted formulations, improved drug delivery methods and enhanced regulatory compliance. Additionally, R&D fosters brand differentiation and strengthens market competitiveness, attracting consumers with advanced, science-backed OTC products. For instance, in December 2023, according to Eurostat, a Luxembourg-based statistical office of the European Union, the EU's expenditure on research and development (R&D) increased to €352 billion ($384.42 billion) in 2022, marking a 6.34% rise from €331 billion ($361.48) in the previous year. Therefore, increasing investment in research and development drove the growth of the over-the-counter (OTC) drugs market.

Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief

Major companies operating in the over-the-counter (OTC) drugs market are focusing on the development of bioequivalent ophthalmic solutions to provide eye allergy relief. It offers the same therapeutic benefits at a potentially more competitive price, presenting an opportunity to drive revenue growth, expand its ophthalmic portfolio and solidify its position in the OTC pharmaceutical market. For instance, in March 2025, Glenmark Pharmaceuticals Inc., a US-based pharmaceutical company, received final approval from the U.S. Food and Drug Administration (FDA) for its olopatadine hydrochloride ophthalmic solution USP, 0.2% (OTC). This product is recognized as bioequivalent to Alcon Laboratories' Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC). Distribution in the U.S. will be managed by Glenmark Therapeutics Inc., USA. With the Pataday market generating approximately $50.7 million in annual sales, this approval presents a strategic growth opportunity for Glenmark to strengthen its ophthalmic portfolio and expand its presence in the over-the-counter eye care segment.

The global over the counter (OTC) drugs markets is fairly fragmented, with large number of players operating in the market. The top 10 competitors in the market made up 14.11% of the total market in 2023.

Over The Counter (OTC) Drugs Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global over the counter (OTC) drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for over the counter (OTC) drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The over the counter (OTC) drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider over the counter (OTC) drugs market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics:- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by formulation type, by distribution channel and by end user.
Key Trends:- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis:- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation:- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by formulation type, by distribution channel and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth:- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape:- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking:- Briefs on the financials comparison between major players in the market.
Competitive Dashboard:- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions:- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments:- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies:- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
Conclusions And Recommendations:- This section includes recommendations for over-the-counter (OTC) drugs market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types
2) By Formulation Type: Tablets; Liquids; Ointments; Sprays; Other Formulation Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Channels
4) By End User: Specialty Clinics; Homecare; Hospitals; Other End Users
Companies Mentioned: Bayer AG; Johnson & Johnson; GlaxoSmithKline PLC; Reckitt Benckiser Group PLC; Sanofi S.A.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; over the counter (OTC) drugs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1657

1 Executive Summary

1.1.1 Over The Counter (OTC) Drugs - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Over The Counter (OTC) Drugs Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Cough, Cold and Flu Products
- 6.4.2 Analgesics
- 6.4.3 Dermatology Products
- 6.4.4 Gastrointestinal Products
- 6.4.5 Vitamins, Minerals and Supplements (VMS)
- 6.4.6 Weight Loss or Dietary Products
- 6.4.7 Ophthalmic Products
- 6.4.8 Sleeping Aids
- 6.4.9 Other Product Types
6.5 Market Segmentation By Formulation Type
- 6.5.1 Tablets
- 6.5.2 Liquids
- 6.5.3 Ointments
- 6.5.4 Sprays
- 6.5.5 Other Formulation Types
6.6 Market Segmentation By Distribution Channel
- 6.6.1 Hospital Pharmacies
- 6.6.2 Retail Pharmacies
- 6.6.3 Online Pharmacies
- 6.6.4 Other Channels
6.7 Market Segmentation By End User
- 6.7.1 Specialty Clinics
- 6.7.2 Homecare
- 6.7.3 Hospitals
- 6.7.4 Other End Users

7 Major Market Trends

7.1 Development of Bioequivalent Ophthalmic Solution to Provide Eye Allergy Relief
7.2 Innovative Fast-Acting OTC Gels For Erectile Dysfunction Treatment
7.3 Launch of Affordable Nasal Spray to Combat Opioid Overdoses
7.4 Groundbreaking Over-the-Counter Birth Control Pill Offers Greater Access
7.5 Innovative OTC Drugs Targeting Diarrhea From Overeating And Overdrinking

8 Over The Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

8.1 Global Over The Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End User (B2B)
- 8.2.1 Specialty Clinics
- 8.2.2 Homecare
- 8.2.3 Hospitals
- 8.2.4 Other End Users
8.3 Over The Counter (OTC) Drugs Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019- 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
- 8.5.1 Market Drivers 2024 - 2029
- 8.5.2 Market Restraints 2024 - 2029
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Over The Counter (OTC) Drugs Total Addressable Market (TAM)

9 Over The Counter (OTC) Drugs Market Segmentation

9.1 Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Over The Counter (OTC) Drugs Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Cough, Cold, And Flu Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Analgesics, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Dermatology Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Gastrointestinal Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.9 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Vitamins, Mineral, And Supplements (VMS), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.10 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Weight Loss Or Dietary Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.11 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Ophthalmic Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.12 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Sleeping Aids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.13 Over The Counter (OTC) Drugs Market, Sub-Segmentation By Other Product Types, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Over The Counter (OTC) Drugs Market, Regional and Country Analysis

10.1 Over The Counter (OTC) Drugs Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Over The Counter (OTC) Drugs Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Over The Counter (OTC) Drugs Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Investments
- 11.33.11 Major Companies
11.34 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.8 UK Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 France Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major companies
13.3 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 USA Market
14.7 Summary
14.8 Market Overview
- 14.8.1 Country Information
- 14.8.2 Market Information
- 14.8.3 Background Information
- 14.8.4 Government Initiatives
- 14.8.5 Regulations
- 14.8.6 Regulatory Bodies
- 14.8.7 Major Associations
- 14.8.8 Taxes Levied
- 14.8.9 Corporate Tax Structure
- 14.8.10 Investments
- 14.8.11 Major Companies
14.9 USA Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.10 USA Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 Canada Market
14.13 Summary
14.14 Market Overview
- 14.14.1 Country Information
- 14.14.2 Market Information
- 14.14.3 Background Information
- 14.14.4 Government Initiatives
- 14.14.5 Regulations
- 14.14.6 Regulatory Bodies
- 14.14.7 Major Associations
- 14.14.8 Taxes Levied
- 14.14.9 Corporate Tax Structure
- 14.14.10 Investments
- 14.14.11 Major Companies
14.15 Canada Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.16 Canada Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 Africa Over The Counter (OTC) Drugs Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Bayer AG
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Johnson & Johnson
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Financial Overview
18.4 GlaxoSmithKline PLC
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Financial Overview
18.5 Reckitt Benckiser Group PLC
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Sanofi S.A.
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Perrigo Company plc
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Haleon plc
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Teva Pharmaceutical Industries Ltd
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 Dr. Reddy's Laboratories
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Cipla Ltd.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Sun Pharmaceutical Industries Ltd
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Amneal Pharmaceuticals Inc.
- 19.7.1 Company Overview
- 19.7.2 products And Services
19.8 Abbott Laboratories
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Boehringer Ingelheim International GmbH
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Glenmark Therapeutics Ltd.
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Alkem Laboratories Ltd.
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 Sonoma Pharmaceuticals Inc.
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Takeda Pharmaceutical Company Ltd
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Viatris (Mylan NV)
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 AFT Pharmaceuticals Ltd.
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Cooper Consumer Health Acquired Viatris Inc.
22.2 Avista Healthcare Partners Acquired Trillium Healthcare Products
22.3 Cipla South Africa Acquired Actor Pharma (Pty) Ltd.
22.4 Glenmark Pharmaceuticals Inc. Acquired Wockhardt USA Inc.

23 Recent Developments in Over The Counter (OTC) Drugs

23.1 New Over-the-Counter Laxative Targets Growing Constipation Demand
23.2 Leveraging Big Data for Seamless Transition to Over-the-Counter Medications
23.3 Enhancing Maternal Health and Infant Development with a New Over-the-Counter Supplement

24 Opportunities And Strategies

24.1 Over The Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
24.2 Over The Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
24.3 Over The Counter (OTC) Drugs Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Over The Counter (OTC) Drugs Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1.1 Geographies Covered
26.1.2 Market Data Sources
26.1.3 Research Methodology
26.1.4 Currencies
26.1.5 The Business Research Company
26.1.6 Copyright and Disclaimer